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Abstract
CD4+ T cell-mediated immunity plays a central role in determining the immunopathogenesis of viral infections. However,
the role of CD4+ T cells in EV71 infection, which causes hand, foot and mouth disease (HFMD), has yet to be elucidated. We
applied a sophisticated method to identify promiscuous CD4+ T cell epitopes contained within the sequence of the EV71
polyprotein. Fifteen epitopes were identified, and three of them are dominant ones. The most dominant epitope is highly
conserved among enterovirus species, including HFMD-related coxsackieviruses, HFMD-unrelated echoviruses and
polioviruses. Furthermore, the CD4+ T cells specific to the epitope indeed cross-reacted with the homolog of poliovirus
3 Sabin. Our findings imply that CD4+ T cell responses to poliovirus following vaccination, or to other enteroviruses to
which individuals may be exposed in early childhood, may have a modulating effect on subsequent CD4+ T cell response to
EV71 infection or vaccine.
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Introduction
HFMD, caused by enteroviruses, is a common illness in children
who are less than 5 years old. HFMD has currently emerged as a
major infectious disease in China, affecting about one million
children annually [1–3]. Currently, there is neither a prophylactic
vaccine nor antiviral therapy to treat the disease. Understanding
the immunopathogenesis of HFMD and the potential cross-
reactive immunity to other viral infections and vaccines may assist
in developing a novel therapy or effective vaccine against HFMD.
The major etiological agents of HFMD are enterovirus 71
(EV71), coxsackievirus (CV) A16 [4,5], and other enteroviruses
including CV serotypes A2, A4, A6, A9, A10, B1, B3 and B5, also
cause mild HFMD [6–11]. EV71 is the most pathogenic virus of
these causative agents, causing severe HFMD with complications
including brainstem encephalitis, severe pulmonary edema, and
significant mortality [12,13].
Several studies suggest that the cellular immune response plays
an important role in controlling EV71 infection. First, the level of
antibody against EV71 does not correlate with disease severity
[2,14]. Peripheral blood mononuclear cells (PBMCs) from severe
HFMD patients tend to have lower proliferation in response to
inactivated EV71 virus [14], suggesting an inverse correlation
between antigen-specific T cell response and disease severity.
Secondly, a case-control study has revealed that selected MHC
class I-restricted CD8+ and class II-restricted CD4+ T cell
responses are involved in susceptibility to EV71 infection [15].
Furthermore, mice that lack either CD4+ or CD8+ T cells develop
severe disease upon infection with mouse-adaptive EV71 [16].
CD4+ T cells are central players in the adaptive immune
response, providing helper signaling for B cells to produce
antibody and CD8+ T cells to become cytotoxic killer cells, and
also by modulating the responses of recruited innate immune cells
[17,18]. Understanding how CD4+ T cells respond to EV71
infection not only sheds light on the pathogenic process but also on
effective vaccine development. Previously, three epitopes within
EV71 VP1 protein were predicted with an online algorithm and
validated for their abilities to induce proliferation of human CD4+
T cells [19]. This contrasts with an earlier study that had suggested
that cross-reactive T cell epitopes exist for enteroviruses, and that
the cross-reactive CD4+ T cell epitopes are located in VP2 and
VP3 proteins rather than VP1 proteins [20]. Epitope mapping for
EV71 should also take into consideration related enteroviruses
such as Polio virus, since poliovirus vaccination is widespread and
most children are exposed to additional enteroviruses during
childhood. Thus, in this study, we considered how immunization
or exposure to other enteroviruses may affect CD4+ T cell
response to EV71 infection of HFMD patients and the efficacy of
EV71 vaccines in clinical trials, and examined whether cross-
conservation contributes to epitope dominance.
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EpiMatrix, a T-cell epitope mapping algorithm, is based on
matrices of coefficients that correspond to the preferred amino
acid residues for each HLA allele. The tool has been successfully
applied to the analysis of previously published epitopes [21], and
in the prospective selection of epitopes from HIV [22], Mycobac-
terium tuberculosis [23], Tularemia [24] vaccinia virus [25],
Burkholderia ([26], http://immunome-research.net/) and H.
pylori [27]. EpiMatrix also been compared in a head-to-head
study with other online tools and was found to be more accurate
for a large database of well-defined class I and class II T cell
epitopes [28]. In the current project, we performed a systematic
review of epitope distribution in the entire EV71 polyprotein,
using EpiMatrix and ClustiMer (a related algorithm for finding
promiscuous T cell epitopes) to analyze our EV71 isolate (FY573,
HM064456). Thirty-seven epitope clusters were predicted and
subsequently examined for immunogenicity by performing ELI-
Spot assays using PBMCs from healthy adults. Fifteen epitopes
elicited detectable T cell responses in these donors, and sequence
analysis revealed two dominant epitopes that were located in the
capsid region. This epitope dominance correlates with the high
degree of sequence conservation among the enteroviruses,
suggesting that poliovirus vaccination in early childhood or
infection with other enteroviruses may determine the immunodo-
minance of CD4+ T cell responses to EV71 infection and to
vaccination with HFMD vaccines.
Materials and Methods
1. Human Subjects and PBMCs
PBMCs from anonymous adult donors were purchased from the
Shanghai Red Cross Center. PBMCs were also separated from
blood samples of HFMD patients at hospital admission and were
collected in the Children’s Hospital of Fudan University. All the
HFMD patients were positive for EV71 in a RT-PCR assay.
Written informed consent was obtained for the use of serum
samples from all participants (or their parents) involved in this
study. This study was approved by the ethics committee of the
Children’s Hospital of Fudan University in accordance with local
governmental guidelines and institutional policies.
2. Synthetic Peptides and Sequence Analysis
Peptides representing the 37 epitopes predicted by EpiMatrix,
variants of A3 epitope, along with those previously indentified
(SP1, SP2, and SP3) and a scrambled control (SP4) [19], were
purchased from the HDbiology company (Shanghai, China). All
the peptides were .95% pure as assessed by high-performance
liquid chromatography. The peptides were firstly dissolved in
dimethyl sulfoxide (DMSO, Sigma, USA) to provide as stock
solution and then diluted in PBS to obtain a 4 mg/ml working
concentration. To identify similar epitopes from other enterovi-
ruses, the amino acid sequences of the synthetic peptides were used
as query sequences in a protein-protein BLAST (blastp 2.2.17)
search using the National Center for Biotechnology Information
database. Sequence information of viral isolates used in this study
can be queried in UniProt Knowledgebase. EV71 isolates include:
ADG57604.1, ADG57603.1, ACF21980.1, ACD63041.1,
ADC84176.1, ADC84177.1, ACI25378.1, ADD84781.1,
ADX87405.1, ACM47545.1, ADC54995.1, ACF60581.1,
ADG57604.1, ADG57603.1, AAR32993.1, ACU45380.1,
ACU45379.1, and Q66478. The other enterovirus isolates
included: CVA4 (Q66478), CVA9 (P21404), CVA16
(ABX55895.1), CVB3 (P03313), CVB5 (Q03053), CVB6
(Q9QL88), EV5 (Q9YLJ1), EV15 (Q6W9G3), EV30 (Q306E5),
Poliovirus 1 strain Sabin (CAA24465.1), Poliovirus 2 strain Sabin
(X00595.1), and Poliovirus 3 strain Sabin (Q84792).
3. IFN-c ELISpot Assays
ELISpot assays were carried out ex vivo with PBMCs as
described previously by others [29]. Briefly, PBMCs were cultured
with the individual predicted peptides or the scrambled peptide
SP4. For validation of the newly predicted CD4+ T cell epitopes,
1.56106 PBMCs were plated per well in triplicate and incubated
overnight at 37uC, 5% CO2, with each peptide at 4 mg/ml. The
wells containing PBMCs with DMSO or 20 mg/ml PHA (Sigma)
served as negative or positive controls, respectively. Note that only
36103 PBMCs were used in the PHA culture. The spot-forming
units (SFU) of the plates were read on an automated ELISpot
reader (Cellular Technology Limited), and the results were
presented as spot-forming units (SFU) per 106 PBMCs. To
examine HLA restriction, 5 mg/ml antibodies against HLA-DP
(Abcam), HLA-DR (Biolegend) and HLA-A, -B and -C (Biolegend)
were added during the peptide stimulation.
4. Intracellular Cytokine Staining and Flow Cytometry
Analysis
Two million PBMCs were cultured with 4 mg/ml each peptide
for 4 days. The cells were then cultured with 50 units/ml
recombinant human IL-2 (R&D Systems) for an additional 3
days. PBMCs from the same patients, which were cultured with
SP4 or with 10 ng/ml PMA (Sigma) and 500 ng/ml ionomycin
(Sigma), served as negative and positive controls respectively. The
cells were washed and re-stimulated with 4 mg/ml indicated
peptides in the presence of 2 mg/ml brefeldin A (Sigma) at 37uC,
5% CO2, for 6 hours. Cells were stained with fluourochrome-
conjugated antibodies against surface markers and then processed
for intracellular cytokine staining (ICS) according to the manu-
facturer’s instruction (eBioscience) before being stained for IFN-c.
Fluorochrome-conjugated antibodies used were aCD4-APC,
aCD8-PE-Cy7, aCD3-PerCP-Cy5.5, and aIFN-c–FITC
(eBioscience). All samples were processed on a BD LSR II and
analyzed using FlowJo software.
To evaluate the cross-reactivity between A3 epitopes of EV71
and poliovirus, PBMCs that were cultured with EV71 A3 peptide
and IL-2 were re-stimulated with 4 mg/ml EV71 A3 or A3 variant
(A3v) of polioviruses in the presence of 2 mg/ml brefeldin A
(Sigma) at 37uC, 5% CO2, for 6 hours. Re-stimulation with 4 mg/
ml SP4 or with 10 ng/ml PMA (Sigma) and 500 ng/ml ionomycin
(Sigma) served as negative and positive controls respectively. The
re-stimulated cells were then processed for surface and intracel-
lular staining.
5. Statistical Analysis
Proportional data were analyzed using Pearson’s chi-squared
test. Student’s t-test was used to determine statistical significance.
All analyses were performed using SPSS software (version 11.5;
SPSS). A difference with p,0.05 was considered to be significant.
Results
A3, A8 and A14 are Dominant Epitopes of EV71
Polyproteins
The entire primary amino acid sequence of an EV71 strain
(FY573) that was isolated from a patient in Fuyang city in 2009 by
our lab was subjected to analysis by the EpiMatrix and ClustiMer
algorithms [30]. Thirty-seven promiscuous EV71 CD4+ T cell
epitopes were predicted, of which 11 were found in structural viral
Heterologous Immunity to HFMD
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protein regions, including VP1, VP2 and VP3 regions. The
remaining predicted epitopes were located throughout the 2A, 2B
and 3D proteins.
Human adults are about 80% seropositive for EV71, suggesting
previous exposure [2]. PBMCs from 6 healthy anonymous (blood
bank) adult donors were obtained and assayed by ELISpot for
IFN-c response to the individual predicted epitopes. Responses to
the three previously published epitopes, SP1, SP2 and SP3, were
examined in parallel. SP4 served as a scrambled control. In all,
each of the 15 predicted epitopes elicited IFN-c production by
PBMCs from at least one of the donors (stimulation index (SI) $
2.0) (Table 1); this level of response is slightly lower than, but
consistent with, previous levels of response to EpiMatrix- and
ClustiMer-predicted epitopes from viral pathogens [36]. Over two
thirds of the immune responses (11/15) were to epitopes located in
capsid protein region. Among these, epitopes A3, A8 and A14
elicited much higher immune responses as measured by SI and
SFUs than the other epitopes (Figure 1A and 1B). All 6 adult
donor PBMCs responded well to A3, with a maximum SI of 52.4
and a maximum of 214 SFU/106 PBMCs; A3 was therefore
defined as the most dominant epitope. Responses to A8 and A14
epitopes were lower than to A3, however, their selected SI’s were
as high as 10 and 4.3, respectively. To our surprise, donor
responses to SP1, SP2 and SP3 were not significantly different
from the mock culture and scrambled peptide, with ELISpot
averages lower than 10 SFU/106 PBMCs (Figure 1C). Only two
subjects (33.3%) had a SI above 2.0 in response to SP1, while none
of subjects responded to SP2 or SP3 epitopes.
A3 and A8 Epitopes are Conservative among EV71
Isolates
Since EV71 is an RNA virus, it lacks a proofreading mechanism
and thus rapid evolution of viral sequence has been observed in
association with the outbreaks occurring across Asia in regular
cycles, and virus gene subgroups seem to differ in clinical
epidemiological properties [31–33]. Many individuals are exposed
to enteroviruses during these outbreaks. Thus, we wondered
whether the dominance of EV71 CD4+ T cell epitopes might be
related to their sequence conservation among circulating EV71
isolates. To address this question, we aligned the amino acid
Figure 1. Identification of two dominant EV71 CD4+ T cell epitopes. (A) The average of spot forming units of PBMCs from 6 adult donors
stimulated with 37 predicted EV71 CD4+ T cell epitopes and a scrambled peptide SP4. (B) These photos of ELISpot wells are examples of the
responses to A3, A8, SP4 and PHA. (C) On average, the spot forming units of A3 and A8 were significantly higher than previously identified CD4+ T cell
epitopes, SP1, SP2 and SP3.
doi:10.1371/journal.pone.0051957.g001
Heterologous Immunity to HFMD
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sequences of SP2, A3, A8 and A14 epitopes in 15 EV71 strains,
which were isolated during the HFMD outbreaks from 2001 to
2010, using the JanusMatrix tool. JanusMatrix searches for
conserved T-cell receptor (TCR) facing sequences while allowing
the HLA binding residues to vary, as long as the peptide is still
presented by the same HLA [De Groot, Bailey-Kellog and Martin,
unpublished data]. Both the A3 and A8 sequences maintained
100% conservation at the TCR facing residues in EV71 isolates,
including the EV71 isolates that had been circulating in the recent
HFMD outbreaks in China (Figure 2A). However, both SP2 and
Table 1. Characteristics of immunogenic peptides.
Peptide Sequence Cluster Address Location
% Reactive
Donors SI* Average ± SD
A1 NAQFHYLYRSGFCIHVQ 164–180 VP2 50 2.863.3
A2 ADGFELQHPYVLDAGISISQL 224–244 VP2 16.7 1.161.0
A3 PHQWINLRTNNCATII 248–263 VP2 100 29.8±18.2
A4 HCNFGLLVVPISPLD 278–292 VP2 50 1.861.5
A6 TGSFMATGKMLIAYTPPGGPLP 445–466 VP3 16.7 2.563.4
A7 IWDFGLQSSVTLVIPWISNTH 479–499 VP3 33.3 1.161.2
A8 NTAYIIALAAAQKNFTMKL 533–551 VP3 83.3 7.3±3.7
A9 SLAWQTATNPSVFVK 733–747 VP1 33.3 1.560.9
A11 NQNYLFKANPNYAGNSI 833–849 VP1 16.7 1.561.4
A12 SRDLLVSSTTAQGCDT 899–914 VP1 16.7 1.161.0
A13 HYPVSFSKPSLIYVE 933–947 VP1 50 1.961.3
A14 SREVEALKNYFIGSE 1034–1048 2A 66.7 2.8±1.1
A19 GLEWVSNKISKFIDWL 1128–1143 2B 33.3 1.161.7
A30 DSVYLRMAFGHLYETF 1914–1929 3D 50 1.461.6
A31 GHLYETFHANPGTITGSA 1923–1940 3D 16.7 0.261.1
*SI represents the fold increase in number of spot-forming cells over background.
doi:10.1371/journal.pone.0051957.t001
Figure 2. The dominant A3 epitope is highly conserved among human enteroviruses. (A) The A3 and A8 epitopes are exactly conserved
across EV71 isolates, other HFMD-related viruses, and polioviruses. A14 was not as well conserved. Of the EV71 strains shown, all except for the EV71
prototype BrCr strain were isolated in the recent HFMD outbreaks. (B) A3, but not A8, was conserved among the other enteroviruses.
doi:10.1371/journal.pone.0051957.g002
Heterologous Immunity to HFMD
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A14, which were less immunodominant epitopes, demonstrated
more sequence variability between isolates.
The most common etiologic agents of HFMD are EV71 and
CVA16. However, in many outbreaks, a number of additional
enteroviruses, such as CVA4, CVA6 and certain echoviruses (EV),
may co-circulate [4,34]. Using the JanusMatrix tool, we evaluated
whether co-circulating enteroviruses shared the same or significant
homology within the amino acid sequences of A3, A8 or A14
epitopes. Detailed sequence analysis revealed that the amino acid
sequence of A3 was identical in the VP2 proteins of CVA4, A6
and A16. In addition, the A3 sequences were also conserved in
HFMD-unrelated enteroviruses, including CVA9, CVB3, CVB5,
CVB6, EV5, EV15, EV30, PV1, PV2 and PV3; albeit with two to
four amino acid differences that did not affect binding to HLA
presentation of the epitope to the TCR. Thus, A3 is an identical
CD4+ T cell epitope in EV71, CVA4, CVA6 and CVA16. In
contrast, the A8 epitope was not conserved among these
enteroviruses (Figure 2B). Altogether, the relative dominance of
A3, as compared to A8, among these epitopes appeared to be
related to its extensive conservation among enteroviruses.
Both A3- and A8-responding T cells are HLA-DR-
restricted CD4+ T cells
To further characterize the nature of the T cell response to A3
or A8 epitopes, we performed intracellular IFN-c staining of
PBMCs obtained from adults, which were stimulated in vitro with
A3 or A8 and subsequently expanded with recombinant IL-2. Our
flowcytometry analysis revealed that the frequency of IFN-c-
producing A3- or A8-specific T cells varied from individual to
individual, with a maximum of 4.60% responding to A3 and
2.70% to A8. The majority of IFN-c-producing A3- or A8-specific
T cells from the three representative volunteers were CD4+ cells
(Figure 3A). In contrast, CD8+ T cells produced only a negligible
Figure 3. Both A3- and A8-specific T cells are HLA-DR-restricted CD4+ T cells. (A) and (B) PBMCs from adult donors were stimulated with A3
or A8 peptides and then expanded with recombinant IL-2. (A) The stimulated PBMCs were stained with fluorescently labeled antibodies against CD3,
CD4, CD8 and IFNc before flow cytometric analysis. Antigen-specific IFNc production was primarily associated with CD4+ T cells. (B) CD8+ T cells
produced negligible level of IFNc in response to A3 or A8. (C) A3 and A8 can induce strong CD4+ cell responses in HFMD patients infected by EV71.
(D) and (E) ELISpot assays were performed to examine IFNc production by PBMCs which were stimulated with A3 (D) or A8 (E) peptides alone or in
presence of blocking antibodies against HLA-DR, HLA-DP, or HLA-A, B and –C (HLA-ABC). The results were shown as average spot forming units 6
standard deviation (n = 3). Only anti-HLADR antibodies abrogated the ELISpot responses, demonstrating that the responses to EV71 are Class II-
restricted.
doi:10.1371/journal.pone.0051957.g003
Heterologous Immunity to HFMD
PLOS ONE | www.plosone.org 5 December 2012 | Volume 7 | Issue 12 | e51957
background level of IFN-c in response to A3 or A8 in all the
volunteers (Figure 3B). Thus, it appears that the A3- and A8-
responding T cells are CD4+ T cells.
Next we evaluated the response of T cells from HFMD patients
to A3 and A8 epitopes (Figure 3C). Consistent with our findings in
healthy adult blood donor subjects, IFN-c-producing cells of
patients’ PBMCs in response to A3 and A8 epitopes were also
CD4+ T cells. Note that the response levels varied in the examined
three patients. In addition, the response levels of A3 and A8
epitopes had a tendency to correlate with each other.
We next investigated the HLA restriction of A3- and A8
epitope-specific CD4+ T cells. We cultured PBMCs obtained from
adults with A3 or A8 peptides in the presence of blocking
antibodies against HLA-DR, HLA-DP or HLA-A, B and -C, and
performed ELISpot assays. Blocking with HLA-DR antibody
inhibited IFN-c secretion by PBMCs in response to A3 and A8 by
90.82% and 85% respectively. The inhibition effect was not
observed when blocking antibodies against other HLA Class II
molecules were used (anti-DP and DQ), or with irrelevant control
anti-HLA-A, B and C antibody (Figure 3D). Thus, the A3 and A8
epitopes appear to be restricted by HLA-DR molecules.
Cross-reactivity of EV71 A3-specific CD4+ T cells with A3v
Epitope of Poliovirus
The EV71 A3 epitope differed from the A3 variant (A3v)
epitopes of poliovirus (PV) Sabin strains 1, 2 and 3 by three amino
acid mutations, respectively (Figure 2B). We evaluated the
potential cross-reactivity between the EV71 and poliovirus
epitopes by testing whether cells exposed to EV71 epitopes would
respond to poliovirus (PV) epitopes. The A3v (variant) epitopes
elicited little to no detectable IFN-c production (Figure 4A).
Nevertheless, PV3 A3v but not PV1/2 A3v elicited measurable
levels of IFN-c production by the PBMCs obtained from adults
that were first stimulated with EV71 A3 epitope and expanded
with recombinant IL-2 (Figure 4B). This result suggests that T cells
responding to the EV71 A3 epitope cross-react with the PV3 A3v
epitope, as was predicted by the JanusMatrix analysis. The cross-
reactivity of the PV3 A3v epitope appeared to be specific to the
EV71 A3 epitope, since the PV3 A3v epitope failed to elicit IFN-c
production of the PBMCs that were first stimulated with the EV71
A8 epitope (Figure 4C).
Figure 4. EV71 A3 or A8-specific CD4+ T cells respond to the poliovirus 3 Sabin (PV3) homolog, A3v peptide. PBMCs from two adult
subjects were cultured in the presence of EV71 A3, EV71 A8, PV3 A3v, or SP4 peptides for 4 days and then with recombinant human IL-2 for additional
3 days. The cells were washed and re-stimulated with SP4, EV71 A3 or PV A39, then surface-stained with fluorescent antibodies against CD3 and CD4
molecules and intracellularly for the production of IFNc. Gated CD3+ cells are shown. (A) SP4 or PV3 A3v-stimulated cells were re-stimulated with the
respective peptides. (B) EV71 A3-stimulated cells were re-stimulated with SP4, EV71 A3 or PV3 A3v, respectively. (C) EV71 A8-stimulated cells were re-
stimulated with SP4, EV71 A8 or PV3 A3v, respectively. The above results were representative data from three independent experiments.
doi:10.1371/journal.pone.0051957.g004
Heterologous Immunity to HFMD
PLOS ONE | www.plosone.org 6 December 2012 | Volume 7 | Issue 12 | e51957
Discussion
In this study, an immunoinforamtics approach was used to
systematically predict CD4+ T cell epitopes in the entire
polyprotein of a contemporary EV71 isolate. To our knowledge,
this is the first time that immunoinformatics tools combining HLA
class II prediction and promiscuity (EpiMatrix and ClustiMer)
were used to evaluate EV71. Among the 37 predicted epitopes, 15
epitopes were found to elicit a T cell response in from HFMD-
exposed adults. A3, A8 and A14 emerged as dominant epitopes in
this analysis, and A3 was the most dominant epitope (recognized
by all the tested donors). Epitopes A3 and A8 are located in the
capsid regions of the VP2 and VP3 proteins, respectively. This
epitope distribution is consistent with a previous study on other
enteroviruses [20]. While protein abundance may be one reason
for epitope dominance, we present evidence here that the
dominance of these epitopes may be attributed to their relative
conservation among circulating EV71 isolates, other HFMD-
related enteroviruses, and poliovirus vaccine strains. Specifically,
the A3 epitope is identical in HFMD-related enteroviruses,
including CVA4, 6, and 16, and it has the propensity to bind to
multiple HLA-DR alleles as predicted by EpiMatrix. It is
interesting to note that, with the exception of EV71, all the
HFMD-related enteroviruses cause only mild illness. Thus, it
would be of interest to investigate whether there is an epidemi-
ological and biological correlation between the primary exposure
to mild HFMD-related enteroviruses and subsequence exposure to
EV71, and whether the primary exposure mitigates the severity of
HFMD, in future studies.
The A3 epitope is also highly conserved in the other HFMD-
related and even HFMD-unrelated coxsackieviruses, echoviruses
and polioviruses. Intracellular staining confirmed that the EV71
A3-specific CD4+ T cells also cross-reacted with the poliovirus
A3v epitope. The A3v epitope is distinct from the previously
identified poliovirus epitopes [35–37]. Nevertheless, the cross-
reactive nature of these epitopes implies the potential for cross-
reactive immune responses related to poliovirus vaccination or
other enteroviruses in early childhood and immunomodulation of
subsequent CD4+ T cell response to EV71 infection or
vaccination.
Low T cell responses to previously identified SP1, SP2 and SP3
epitopes and to poliovirus A3 variants were unexpected. This
result seems to contradict a previous study by Foo et al. However,
their method, which utilized dendritic cells as antigen-presenting
cells, may not be strictly comparable to our PBMC ELISpot
assays. An additional explanation for the disparate results could be
that our subjects express different HLA molecules, or that the
frequency or affinity of memory T cells in the examined PBMCs
specific to the previously published epitopes is lower than the
epitopes that we identified. Nevertheless, the strong immune
response of our subjects to the A3 epitope suggests that this epitope
should be the focus of evaluation by more sensitive assays in future
clinical studies.
While cross-strain immunity may not necessarily provide
sterilizing immunity against new emerging infections, it may
mitigate the severity of disease. For example, we demonstrated
that cross-reactive influenza-specific memory CD4+ T cells were
present prior to the introduction of pandemic H1N1, and have
postulated that they play an important role in reducing the disease
severity of pandemic H1N1 infection in humans [38,39]. As shown
here, poliovirus vaccination may have an impact on subsequent
severity of HFMD disease [40]. Cross-reactivity between EV71 A3
epitope and the A3v epitope of poliovirus 3 Sabin strain, may lead
to the stimulation of protective, cross-reactive T cell responses,
limiting the severity of subsequent HFMD.
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